Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza
Риск ишемического инсульта у пациентов с коронавирусной болезнью 2019 года (COVID-19) по сравнению с пациентами с гриппом
2020-07-02
SCID: 54.1/2ushsh8j
Discuss with AI
COVID-19influenzaischemic strokelogistic regressionretrospective cohort study
Figures from the paper
Abstract (AI)
IMPORTANCE: It is uncertain whether coronavirus disease 2019 (COVID-19) is associated with a higher risk of ischemic stroke than would be expected from a viral respiratory infection. OBJECTIVE: To compare the rate of ischemic stroke between patients with COVID-19 and patients with influenza, a respiratory viral illness previously associated with stroke. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted at 2 academic hospitals in New York City, New York, and included adult patients with emergency department visits or hospitalizations with COVID-19 from March 4, 2020, through May 2, 2020. The comparison cohort included adults with emergency department visits or hospitalizations with influenza A/B from January 1, 2016, through May 31, 2018 (spanning moderate and severe influenza seasons). EXPOSURES: COVID-19 infection confirmed by evidence of severe acute respiratory syndrome coronavirus 2 in the nasopharynx by polymerase chain reaction and laboratory-confirmed influenza A/B. MAIN OUTCOMES AND MEASURES: A panel of neurologists adjudicated the primary outcome of acute ischemic stroke and its clinical characteristics, mechanisms, and outcomes. We used logistic regression to compare the proportion of patients with COVID-19 with ischemic stroke vs the proportion among patients with influenza. RESULTS: Among 1916 patients with emergency department visits or hospitalizations with COVID-19, 31 (1.6%; 95% CI, 1.1%-2.3%) had an acute ischemic stroke. The median age of patients with stroke was 69 years (interquartile range, 66-78 years); 18 (58%) were men. Stroke was the reason for hospital presentation in 8 cases (26%). In comparison, 3 of 1486 patients with influenza (0.2%; 95% CI, 0.0%-0.6%) had an acute ischemic stroke. After adjustment for age, sex, and race, the likelihood of stroke was higher with COVID-19 infection than with influenza infection (odds ratio, 7.6; 95% CI, 2.3-25.2). The association persisted across sensitivity analyses adjusting for vascular risk factors, viral symptomatology, and intensive care unit admission. CONCLUSIONS AND RELEVANCE: In this retrospective cohort study from 2 New York City academic hospitals, approximately 1.6% of adults with COVID-19 who visited the emergency department or were hospitalized experienced ischemic stroke, a higher rate of stroke compared with a cohort of patients with influenza. Additional studies are needed to confirm these findings and to investigate possible thrombotic mechanisms associated with COVID-19.
Key Findings
1
After adjustment for age, sex, and race, COVID-19 was associated with a higher likelihood of ischemic stroke than influenza (odds ratio, 7.6; 95% CI, 2.3-25.2).
2
Among 1,486 patients with influenza, 3 (0.2%; 95% CI, 0.0%-0.6%) experienced acute ischemic stroke.
3
Among 1,916 patients with COVID-19, 31 (1.6%; 95% CI, 1.1%-2.3%) experienced acute ischemic stroke.
4
Patients with COVID-19-related stroke had a median age of 69 years, and 58% were men; stroke prompted hospital presentation in 26% of cases.
5
The association between COVID-19 and increased ischemic stroke risk persisted across sensitivity analyses.
Research Object
Adult patients with laboratory-confirmed COVID-19 or influenza A/B presenting to academic hospitals
Research Subject
Comparative risk, clinical characteristics, mechanisms, and outcomes of acute ischemic stroke associated with COVID-19 versus influenza infection
Publication Details
Publication Date
2020-07-02
Journal
Publisher
ISSN
Cited by
963
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.1993
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
SARS-CoV-2 and Stroke in a New York Healthcare System2020
Cited by9
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review2020
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association2021
Stroke in COVID-19: A systematic review and meta-analysis2020
The Impact of COVID-19 Disease on Platelets and Coagulation2020
Neurovascular injury with complement activation and inflammation in COVID-192022
Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-192020
Neurological complications and infection mechanism of SARS-CoV-22021
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐192021
COVID‐19 and ischemic stroke2021